Qiagen Secures FDA Clearance for First QIAstat-Dx Bloodstream Infection Test in the US
As reported on PharmaBiz, Qiagen has received US Food and Drug Administration (FDA) clearance for its QIAstat-Dx BCID GPF Plus AMR Panel, marking the company's entry into the US bloodstream…
Continue Reading
Qiagen Secures FDA Clearance for First QIAstat-Dx Bloodstream Infection Test in the US
